When testing the superiority of apoB/apoA1 over apoB alone, they found that the difference was not statistically significant when adjusting for risk factors, such as obesity, smoking, dyslipidemia, hypertension, diabetes, and high C-reactive protein (CRP). This evidence concerns the gene APOB and diabetes mellitus.